Apr 26, 2021Why Should Early-Stage Biotechs Care about Intellectual Property?Hester Sheehan, Research Scientist at Arctoris, reflects on her IP journey on World Intellectual Property Day. — April 26th is World Intellectual Property Day and as someone about to embark on a career in this field, I thought this would be a timely opportunity to discuss my thoughts on the importance of intellectual property (IP) for early-stage companies and also to reflect on the intellectual property experience…Biotechnology4 min readBiotechnology4 min read
Mar 25, 2021Early-Stage Drug Discovery and the Importance of High-Quality DataGoodwin-Arctoris Drug Discovery Masterclass Recap — Professionals in drug discovery and development face difficult odds: on average, it takes 12 to 15 years to take a new drug from the idea stage to market approval; that is around one-third of a scientist’s professional life! The costs are eye-watering as well: the price tag of taking a…Drug Discovery8 min readDrug Discovery8 min read
Mar 4, 2021COVID-19 in the Crosshairs: Reflections on Developing a Collaboration with BMG LabTechDan Thomas, Head of Discovery Biology at Arctoris, discusses data precision and new partnerships in light of new global health challenges. This blog follows from Dan’s recent workshop at ELRIG UK. — SARS-CoV-2 is not the first time a highly contagious coronavirus spread from the animal kingdom into the human population. And chances are it won’t be the last. If viruses continue to be a threat and evolve, we must continuously adapt our approaches to protecting our populations’ health as well.Artificial Intelligence4 min readArtificial Intelligence4 min read
Feb 25, 2021Why Should You Automate Your Experiments?Poppy Roworth, Head of Laboratory at Arctoris, responds to the big question. — I started a very long blog post during my PhD based on my experiences of science, aimed primarily at my non-scientific friends. I never finished it, mostly because of time constraints around my PhD and also because it became long and waffly. I will endeavour to do better here. Part…Automation6 min readAutomation6 min read
Feb 11, 2021Arctoris celebrates the International Day of Women and Girls in Science 2021Women of Arctoris reflect on their science idols and career journeys — Today is the International Day of Women and Girls in Science. It’s a fantastic opportunity for us to remind all of us of the need to commit to equality in participation in science, technology, engineering, and mathematics (STEM). According to UN Women, just 30% of researchers worldwide are women, and…Women In STEM7 min readWomen In STEM7 min read
Feb 4, 2021Celebrating Five Years of ArctorisArctoris’ co-founders, Martin-Immanuel Bittner and Tom Fleming look back on how Arctoris was born and how we got to where we are today. — Arctoris has turned 5 today! We are thrilled to see where we are now, and how far we have come. We have had a lot of fun and success, have overcome many challenges, and have learned a lot while pursuing our mission to empower scientists around the world. …Biotech7 min readBiotech7 min read
Jan 28, 20215 Myths About Laboratory AutomationIn Daniel Susskind’s A World Without Work: Technology, Automation and How We Should Respond published last year, he argues that economic growth is inseparable from automation. …Automation4 min readAutomation4 min read
Jan 14, 2021Young Scholars at a Young Company: Meet our InternsOur relationship with the University of Oxford starts with our founders who met there while completing their doctorates, and includes the background of many of our team. Now we are thrilled to support the University’s Crankstart Internship programme. …Internships4 min readInternships4 min read
Dec 21, 20202020: A Significant Year for Drug Discovery and UsArctoris’ CEO and Co-Founder Martin-Immanuel Bittner reflects on what this momentous year meant for us, as we look to times ahead for more opportunities to contribute to public health issues. 2020 has been a rather eventful year for all of us — and our thoughts are with all who have…20204 min read20204 min read
Dec 17, 2020From Eroom’s Law to Moore’s Law: Drug Discovery in the 21st CenturyFrom the lab to the patient The number of possible drug-like molecules can baffle the imagination. There are more than 10⁶⁰ compounds in this molecular haystack, though only a tiny proportion of these compounds will meet all the requirements to become a safe and effective medicine. Over the past millennia, we found a handful of needles…Drug Discovery6 min readDrug Discovery6 min read
